Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid has anti-HIV activity. It shows an inhibitory effect on the activation of Epstein-Barr virus early antigen (EBV-EA) induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and causes a significant delay of two-stage carcinogenesis on mouse skin.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 11,800 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 14,200 | 待询 |
产品描述 | 2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid has anti-HIV activity. It shows an inhibitory effect on the activation of Epstein-Barr virus early antigen (EBV-EA) induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and causes a significant delay of two-stage carcinogenesis on mouse skin. |
分子量 | 486.68 |
分子式 | C30H46O5 |
CAS No. | 176983-21-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
2alpha,19alpha-Dihydroxy-3-oxo-urs-12-en-28-oic acid 176983-21-4 Microbiology/Virology Proteases/Proteasome HIV Protease 2alpha,19alpha Dihydroxy 3 oxo urs 12 en 28 oic acid 2a,19a-Dihydroxy-3-oxo-urs-12-en-28-oic acid 2alpha,19alphaDihydroxy3oxours12en28oic acid 2α,19α-Dihydroxy-3-oxo-urs-12-en-28-oic acid Inhibitor inhibitor inhibit